Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

Clinical trial NCT06634199 · RECRUITING

Trial details

NCT number: NCT06634199
Sponsor: Fundación GECP
Status: RECRUITING
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer Stage III PDL1 Gene Mutation

Start date: 2024-10-03
Primary completion: 2027-11-04
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.